or overweight if their BMI is greater than 27 accompanied by weight-related medical problems such as high blood pressure, type 2 diabetes, or high cholesterol
Patients who may benefit from discussing LDN with a Provn provider include: Those with significant needle anxiety that GLP-1 therapy would compound Those with a history of pancreatitis or other GLP-1 contraindications Those with autoimmune conditions who havent responded to conventional weight management approaches Those experiencing chronic inflammation that may contribute to metabolic difficulty Those who have tried GLP-1 therapy without success or with intolerable side effects LDN is taken as a daily oral capsule at bedtime, avoiding the storage, injection, and travel logistics associated with GLP-1 injectable therapy
Simply store it in a cool, dry place away from direct sunlight to maintain potency
I'll link to these studies for you
Refrigerate the reconstituted vial immediately at 28C and use it within 28 days
Resources: Zandvakili, I., & Perez-Tilve, D